U.S. Department of Health and Human Services, National Institutes of Health
Extramural Research Programs in the Neurosciences and Neurological Disorders
Key facts
Open now
- CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) · Due Oct 16, 2026 · 9 days left
- HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) · Due Oct 30, 2026 · 23 days left
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) · Due Nov 10, 2026 · 34 days left
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) · Due Nov 18, 2026 · 42 days left
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) · Due Nov 18, 2026 · 42 days left
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) · Due Nov 19, 2026 · 43 days left
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) · Due Nov 23, 2026 · 47 days left
- Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) · Due Dec 2, 2026 · 56 days left
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) · Due Dec 3, 2026 · 57 days left
- Emerging Global Leader Award (K43 Independent Clinical Trial Required) · Due Dec 3, 2026 · 57 days left
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) · Due Dec 4, 2026 · 58 days left
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) · Due Jan 7, 2027 · 92 days left
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) · Due Jan 15, 2027 · 100 days left
- HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) · Due Jan 26, 2027 · 111 days left
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) · Due Jan 26, 2027 · 111 days left
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) · Due Jan 27, 2027 · 112 days left
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) · Due Jan 28, 2027 · 113 days left
- Translational Neural Devices (R61/R33 - Clinical Trial Optional) · Due Jan 28, 2027 · 113 days left
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) · Due Feb 8, 2027 · 124 days left
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) · Due Feb 11, 2027 · 127 days left
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) · Due Apr 5, 2027 · 180 days left
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) · Due Apr 5, 2027 · 180 days left
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) · Due May 7, 2027 · 212 days left
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) · Due May 7, 2027 · 212 days left
- Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) · Due May 7, 2027 · 212 days left
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) · Due May 7, 2027 · 212 days left
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) · Due May 7, 2027 · 212 days left
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) · Due May 7, 2027 · 212 days left
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) · Due May 7, 2027 · 212 days left
- Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) · Due May 8, 2027 · 213 days left
- Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) · Due May 8, 2027 · 213 days left
- Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) · Due May 8, 2027 · 213 days left
- BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) · Due Jun 15, 2027 · 251 days left
- BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) · Due Jun 15, 2027 · 251 days left
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) · Due Jul 12, 2027 · 278 days left
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional) · Due Jul 17, 2027 · 283 days left
- Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) · Due Aug 18, 2027 · 315 days left
- Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) · Due Sep 7, 2027 · 335 days left
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) · Due Sep 7, 2027 · 335 days left
- BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) · Due Oct 4, 2027 · 362 days left
- Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) · Due Oct 8, 2027 · 366 days left
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) · Due Oct 20, 2027 · 378 days left
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) · Due Oct 20, 2027 · 378 days left
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) · Due Oct 20, 2027 · 378 days left
- Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed) · Due Oct 28, 2027 · 386 days left
- Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required) · Due Nov 5, 2027 · 394 days left
- BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) · Due Nov 8, 2027 · 397 days left
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) · Due Nov 12, 2027 · 401 days left
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) · Due Nov 12, 2027 · 401 days left
- Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) · Due Nov 16, 2027 · 405 days left
- NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) · Due Jan 7, 2028 · 457 days left
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) · Due Jan 7, 2028 · 457 days left
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- NIH Research Project Grant (Parent R01 Clinical Trial Required) · Due Jan 7, 2028 · 457 days left
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) · Due Jan 7, 2028 · 457 days left
- Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) · Due Jan 28, 2028 · 478 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) · Due May 4, 2028 · 575 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) · Due May 7, 2028 · 578 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) · Due May 7, 2028 · 578 days left
- BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed) · Due Jun 23, 2028 · 625 days left
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) · Due Jul 7, 2028 · 639 days left
- Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) · Due Sep 7, 2028 · 701 days left
- Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) · Due Sep 7, 2028 · 701 days left
- Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed) · Due Oct 9, 2028 · 733 days left
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) · Due Nov 30, 2028 · 785 days left
- Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed) · Due Jan 26, 2029 · 842 days left
- BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) · Due Feb 8, 2029 · 855 days left
- HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) · Due Feb 20, 2029 · 867 days left
- NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required) · Due Mar 9, 2029 · 884 days left
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) · Due Apr 5, 2029 · 911 days left
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) · Due Apr 5, 2029 · 911 days left
- Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed) · Due Apr 8, 2029 · 914 days left
- NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) · Due Apr 17, 2029 · 923 days left
- NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed) · Due May 5, 2029 · 941 days left
- NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) · Due May 5, 2029 · 941 days left
- NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed) · Due May 25, 2029 · 961 days left
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) · Due Jul 5, 2029 · 1002 days left
- Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed) · Due Jul 12, 2029 · 1009 days left
- Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed) · Due Jul 12, 2029 · 1009 days left
Opening soon
Announced, but you can't apply yet. Get ready now.
- Small Business Translator: MedTech and Digital Health Technologies · The funder's estimated date (Oct 20, 2025) has passed. Check the official notice Estimate, not confirmed by the funder
- HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) · The funder's estimated date (Jan 5, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Notice of Intent to Publish a Funding Opportunity Announcement for Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research (RM1 - Clinical Trial Optional) · The funder's estimated date (Feb 6, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed) · The funder's estimated date (Feb 20, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Forecast for NINDS Exploratory Grant Program in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research (P20 - Clinical Trial Optional) · The funder's estimated date (Feb 25, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection – Network Sites and Coordinating Center (U01- CT Not Allowed) · The funder's estimated date (Mar 18, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Forecast for NIH Blueprint and BRAIN Initiative ACTION Potential Program (F99/K00 Clinical Trial Not Allowed) · The funder's estimated date (Mar 20, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Therapeutic Agent Characterization and Preclinical Efficacy Studies · The funder's estimated date (Sep 30, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification · The funder's estimated date (Sep 30, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD) · The funder's estimated date (Oct 1, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Exposomic Contributions to ADRD Pathology and Resilience · The funder's estimated date (Oct 5, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- HEAL Initiative: Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins and the Nature of (PRECISION) Human Pain Network · Due about Oct 12, 2026 Estimate, not confirmed by the funder
- HEAL Initiative: Optimization of Therapeutic Medical Devices through Team Science Mechanistic Research (RM1) · Due about Oct 30, 2026 Estimate, not confirmed by the funder
- Functional Target Validation for Alzheimer's Disease-Related Dementias · Due about Nov 6, 2026 Estimate, not confirmed by the funder
- Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required) · Opens Oct 10, 2026 · due about Nov 10, 2026 Estimate, not confirmed by the funder
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) · Due about Nov 10, 2026 Estimate, not confirmed by the funder
- BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System · Opens Dec 10, 2026 · due about Jan 28, 2027 Estimate, not confirmed by the funder
- Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Enrollment Hubs · Opens Jan 4, 2027 · due about Mar 4, 2027 Estimate, not confirmed by the funder
- Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC) · Opens Jan 4, 2027 · due about Mar 4, 2027 Estimate, not confirmed by the funder
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) · Opens Mar 1, 2027 · due about May 25, 2027 Estimate, not confirmed by the funder
- Undiagnosed Diseases Network (UDN) Clinical Networks of Diagnostic Excellence · Opens Mar 25, 2027 · due about May 25, 2027 Estimate, not confirmed by the funder
- Undiagnosed Diseases Network (UDN) Clinical and Data Coordinating Center · Opens Mar 25, 2027 · due about May 25, 2027 Estimate, not confirmed by the funder
- Undiagnosed Diseases Network (UDN) Diagnostic Research Innovation Center · Opens Mar 25, 2027 · due about May 25, 2027 Estimate, not confirmed by the funder
- Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral Sciences · Opens Apr 23, 2027 · due about May 25, 2027 Estimate, not confirmed by the funder
- Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development · Opens Nov 15, 2026 · due about Jun 16, 2027 Estimate, not confirmed by the funder
- Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships · Opens Jan 9, 2027 · due about Jun 17, 2027 Estimate, not confirmed by the funder
- Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Coordinating Center (CCC) & Data Coordinating Center (DCC) · Opens Sep 1, 2027 · due about Nov 1, 2027 Estimate, not confirmed by the funder
- Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Research Sites (U24 Clinical Trial Not Allowed) · Opens Sep 1, 2027 · due about Nov 1, 2027 Estimate, not confirmed by the funder
- NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – National Coordinating Center (NCC) and National Data Management Center (NDMC) · Opens Dec 20, 2027 · due about Jan 25, 2028 Estimate, not confirmed by the funder
- NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – Regional Coordinating Stroke Centers (RCCs) · Opens Dec 20, 2027 · due about Jan 25, 2028 Estimate, not confirmed by the funder
What it pays for
(1) To support extramural research funded by the National Institute of Neurological Disorders and Stroke (NINDS) including: basic research that explores the fundamental structure and function of the brain and the nervous system; research to understand the causes and origins of pathological conditions of the nervous system with the goal of preventing these disorders; research on the natural course of neurological disorders; improved methods of disease prevention; new methods of diagnosis and treatment; drug development; development of neural devices; clinical trials; and research training in basic, translational and clinical neuroscience. The Institute is the largest funder of basic neuroscience in the US and supports research on topics including but not limited to: development of the nervous system, including neurogenesis and progenitor cell biology, signal transduction in development and plasticity, and programmed cell death; synapse formation, function, and plasticity; learning and memory; channels, transporters, and pumps; circuit formation and modulation; behavioral and cognitive neuroscience; sensorimotor learning, integration and executive function; neuroendocrine systems; sleep and circadian rhythms; and sensory and motor systems. In addition, the Institute supports basic, translational and clinical studies on a number of disorders of the nervous system including (but not limited to): stroke; traumatic injury to the brain, spinal cord and peripheral nervous system; neurodegenerative disorders; movement disorders; brain tumors; convulsive disorders; infectious...
Who can apply
Research Grants: Any public, private, nonprofit, or for-profit institution is eligible to apply. For-profit institutions are not eligible for Institutional National Research Service Awards but are eligible for Individual NRSAs. All proposals are reviewed for scientific merit, for evaluation of the qualifications of the investigators, for adequacy of the research environment, and for significance of the problem. Approved proposals compete for available funds. All Career Development Program awardees, with the exception of awardees of the Pathway to Independence Award (K99/R00), must be citizens or have been admitted to the United States for permanent residence. Candidates must be nominated for the program by a nonfederal public or private nonprofit institution located in the United States, its possessions or territories. To be eligible, postdoctoral NRSA trainees or fellows must have a professional or scientific degree (M.D., Ph.D., D.D.S., D.O., D.V.M., Sc.D., D. Eng., or equivalent domestic or foreign degree). SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed, and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the...
How applications are judged
The major elements in evaluating proposals include assessments of: (1) the scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) the soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) the degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific...
Match
None required (federal program listing).
Who in Tennessee has won this program
23 awards to Tennessee groups since 1993 · 12 in Davidson County. Largest shown:
| Past winner | Where | Amount | Fiscal year |
|---|---|---|---|
| Vanderbilt University Medical Center | Nashville, Davidson County | $11.5M spent that year | 2025 |
| Vanderbilt University | Nashville | $9.8M spent that year | 2025 |
| State of Tennessee | Nashville | $9.4M spent that year | 2025 |
| St. Jude Children's Research Hospital, Inc. | Memphis, Shelby County | $7.7M spent that year | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $7.6M | 2012 |
| St Jude Children's Research Hospital Inc | Memphis, Shelby County | $7.1M | 2017 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $5.3M | 2016 |
| University of Tennessee | Memphis, Shelby County | $5.3M | 2002 |
| St Jude Children's Research Hospital Inc | Memphis, Shelby County | $5.2M | 1998 |
| Vanderbilt University | Nashville, Davidson County | $4.7M | 2001 |
| Vanderbilt University | Nashville, Davidson County | $4.6M | 2016 |
| Vanderbilt University | Nashville, Davidson County | $4.1M | 1993 |
Source: Federal Audit Clearinghouse, USAspending.gov.
Tennessee groups that got this money through a state agency or another organization
This federal money also reaches local groups as pass-through grants. 83 pass-through grants on file · 46 in Davidson County. Largest shown:
| Past winner | Where | Through | Amount | Fiscal year |
|---|---|---|---|---|
| Vanderbilt University | Nashville, Davidson County | Yale Univ | $1.6M | 2023 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Vanderbilt University | $1.1M spent that year | 2025 |
| St Jude Children's Research Hospital Inc | Memphis, Shelby County | University of Miami | $654K | 2023 |
| St Jude Children's Research Hospital Inc | Memphis, Shelby County | University of Miami | $588K | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | The University of Iowa | $538K | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | University of Iowa | $516K spent that year | 2025 |
| St. Jude Children's Research Hospital, Inc. | Memphis, Shelby County | Mayo Clinic - Jacksonville Fl | $513K spent that year | 2024 |
| Vanderbilt University Medical Center | Nashville, Davidson County | University of Pittsburgh | $512K spent that year | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | University of Utah | $441K | 2025 |
| St Jude Children's Research Hospital Inc | Memphis, Shelby County | Mayo Clinic Jacksonville (A Nonprofit Corporation) | $431K | 2024 |
| Vanderbilt University | Nashville | Vanderbilt University Medical Center | $421K spent that year | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | New York University | $388K | 2024 |
Source: USAspending.gov pass-through reports (the first recipient reports each one of $30,000 or more).